Weekly CFO Sells Highlight: AthenaHealth Inc, Gilead Sciences Inc, JPMorgan Chase & Co.

Author's Avatar
Apr 20, 2014

According to GuruFocus Insider Data, the recent CFO sales were: AthenaHealth Inc, Gilead Sciences Inc, and JPMorgan Chase & Co.

AthenaHealth Inc (ATHN): CFO and SVP Timothy M Adams sold 30,000 Shares

On 02/18/2014, CFO and SVP Timothy M Adams sold 30,000 shares at an average price of $194.58. The price of the stock has decreased by 25.18% since. AthenaHealth Inc. has a market cap of $5.44 billion and its shares were traded at around $145.58. The company has a P/E ratio of 8563.70 and P/S ratio of 9.40. Over the past 5 years, AthenaHealth Inc. had an annual average earnings growth of 23.90%.

AthenaHealth Inc announced their 2014 fourth quarter results with revenues of $171.58 million and gross profit of $108.7 million; the net income was $13.1 million. The 2013 total revenue was $595 million, a 41% increase from the 2012 total revenue. The 2013 gross profit was $356.3 million, a 40% increase from the 2012 gross profit. The 2013 net income was $2.6 million.

On 04/02/2014, CEO and President Jonathan Bush sold 1,000 shares at an average price of $161.74. The price of the stock has decreased by 9.99% since. On 04/16/2014, President, Enterprise Services Stephen N Kahane sold 10,000 shares at an average price of $143.96. The price of the stock has increased by 1.13% since. On 04/14/2014, Director David Eric Robinson sold 60,000 shares at an average price of $140.61. The price of the stock has increased by 3.53% since.

Gilead Sciences Inc (GILD): EVP, CFO Robin L Washington sold 30,600 Shares

On 02/28/2014, EVP, CFO Robin L Washington sold 30,600 shares at an average price of $83.65. The price of the stock has decreased by 16.32% since. Gilead Sciences Inc has a market cap of $107.68 billion and its shares were traded at around $70,000 with a P/E ratio of 38.30 and P/S ratio of 10.60. Over the past 5 years, Gilead Sciences Inc had an annual average earnings growth of 8.20%.

Gilead Sciences Inc announced their 2013 fourth quarter results with revenues of $3.12 billion and gross profit of $2.26 billion; the net income $781.4 million. The 2013 total revenue was $11.2 billion, a 15% increase. The 2013 gross profit was $8.34 billion, a 15% increase from the 2012 gross profit. The 2013 net income was $3.1 billion.

On 04/14/2014, EVP, R&D and CSO Norbert W Bischofberger sold 90,000 shares at an average price of $67.03. The price of the stock has increased by 4.43% since. On 04/08/2014, EVP Commercial Ops Paul Rutherford Carter sold 16,728 shares at an average price of $70.53. The price of the stock has decreased by 0.75% since. On 04/08/2014, Director John Francis Cogan sold 5,000 shares at an average price of $70.55. The price of the stock has decreased by 0.78% since.

JPMorgan Chase & Co (JPM, Financial): CFO Marianna Lake sold 4,879 Shares

On 04/14/2014, CFO Marianne Lake sold 4,879 shares at an average price of $54.89. The price of the stock has increased by 0.6% since. JPMorgan Chase & Co has a market cap of $209.11 billion and its shares were traded at around $55.22. The company has a P/E ratio of 13.00 and P/S ratio of 2.20 with a dividend yield of 2.80%. Over the past 10 years, JPMorgan Chase & Co had an annual average earnings growth of 9.30%.

JPMorgan Chase & Co announced their 2013 fourth quarter results with a revenue and gross profit of $23.05 billion; the net income was $5.3 billion. The 2013 total revenue and gross profit of JPMorgan Chase & Co was $96.38 billion, a 3% increase from the 2012 total revenue and gross profit. The 2013 net income was $17.9 billion.

On 01/31/2014, Director James S Crown bought 500,000 shares at an average price of $55.54. The price of the stock has decreased by 0.56% since. On 04/14/2014, General Counsel Stephen M Cutler sold 43,997 shares at an average price of $54.91. The price of the stock has increased by 0.56% since. On 04/14/2014, Director Human Resources John L Donnelly sold 9,851 shares at an average price of $54.91. The price of the stock has increased by 0.55% since.